Bio-Techne Corporation
US ˙ NasdaqGS ˙ US09073M1045

SecurityTECH / Bio-Techne Corporation
InstitutionJJJ Advisors Inc.
Latest Disclosed Ownership107 shares
Latest Disclosed Value $ 7,667
JJJ Advisors Inc. ownership in TECH / Bio-Techne Corporation

On July 25, 2024 - JJJ Advisors Inc. filed a 13F-HR form disclosing ownership of 107 shares of Bio-Techne Corporation (US:TECH) valued at $7,667 USD as of June 30, 2024. The entity filed a previous 13F-HR on April 15, 2024 disclosing 107 shares of Bio-Techne Corporation. This represents a change in shares of 0.00% during the quarter. The current value of the position is $5,690 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-07-25 2024-06-30 13F BIO-TECHNE COM 09073M104 107 0 0.00 8 0.00 0.0016
2024-04-15 2024-03-31 13F BIO-TECHNE COM 09073M104 107 0 0.00 8 -12.50 0.0016
2024-01-29 2023-12-31 13F BIO-TECHNE COM 09073M104 107 35 48.61 8 100.00 0.0020
2023-10-13 2023-09-30 13F BIO-TECHNE COM 09073M104 72 0 0.00 5 -20.00 0.0013
2023-07-11 2023-06-30 13F BIO-TECHNE COM 09073M104 72 -27 -27.27 6 -37.50 0.0016
2023-04-21 2023-03-31 13F BIO-TECHNE COM 09073M104 99 -158 -61.48 8 -61.90 0.0024
2023-01-23 2022-12-31 13F BIO-TECHNE COM 09073M104 257 165 179.35 21 -19.23 0.0059
2022-10-17 2022-09-30 13F BIO-TECHNE COM 09073M104 92 -87 -48.60 26 -62.32 0.0085
2022-08-03 2022-06-30 13F BIO-TECHNE COM 09073M104 179 -5 -2.72 69 -13.75 0.0205
2022-05-05 2022-03-31 13F BIO-TECHNE COM 09073M104 184 4 2.22 80 -13.98 0.0221
2022-02-02 2021-12-31 13F BIO-TECHNE COM 09073M104 180 -1 -0.55 93 5.68 0.0278
2021-10-25 2021-09-30 13F/A-1 BIO-TECHNE COM 09073M104 181 15 9.04 88 17.33 0.0311
2021-10-19 2021-09-30 13F BIO-TECHNE COM 09073M104 181 15 88 0.0309
2021-07-28 2021-06-30 13F BIO-TECHNE COM 09073M104 166 8 5.06 75 25.00 0.0272
2021-04-28 2021-03-31 13F BIO-TECHNE COM 09073M104 158 21 15.33 60 36.36 0.0239
2021-01-26 2020-12-31 13F BIO-TECHNE COM 09073M104 137 126 1,145.45 44 1,366.67 0.0213
2020-10-19 2020-09-30 13F BIO-TECHNE COM 09073M104 11 5 83.33 3 50.00 0.0016
2020-07-17 2020-06-30 13F BIO-TECHNE COM 09073M104 6 6 2 0.0011
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.